Among GDM patients with a prepregnancy BMI ≥29 kg/m2, carriers of the MTNR1B rs10830963 G risk allele presented a five-fold higher rate of antenatal insulin therapy (AIT) initiation [214]. The gene discussed is MTNR1B; the disease is gestational diabetes.